These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 17293258)

  • 21. Use of recombinant activated factor VII in massive postpartum haemorrhage.
    Bouma LS; Bolte AC; van Geijn HP
    Eur J Obstet Gynecol Reprod Biol; 2008 Apr; 137(2):172-7. PubMed ID: 17928129
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Treatment of obstetric hemorrhage with recombinant activated factor VII (rFVIIa).
    Segal S; Shemesh IY; Blumenthal R; Yoffe B; Laufer N; Ezra Y; Levy I; Mazor M; Martinowitz U
    Arch Gynecol Obstet; 2003 Oct; 268(4):266-7. PubMed ID: 14504866
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Guidelines for the use of recombinant activated factor VII in massive obstetric haemorrhage.
    Welsh A; McLintock C; Gatt S; Somerset D; Popham P; Ogle R
    Aust N Z J Obstet Gynaecol; 2008 Feb; 48(1):12-6. PubMed ID: 18275566
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Use of recombinant activated factor VII for massive postpartum hemorrhage.
    Hossain N; Shansi T; Haider S; Soomro N; Khan NH; Memon GU; Farzana T; Ansari S; Triche EW; Kuczynski E; Lockwood CJ; Paidas MJ
    Acta Obstet Gynecol Scand; 2007 Oct; 86(10):1200-6. PubMed ID: 17851797
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Use of recombinant factor VIIa for the control of massive bleeding caused by uterine hypotonia in post-placental period].
    Tanchev S; Platikanov V; Markova S; Slavov N; Bogdanova A; Dimitrova D
    Akush Ginekol (Sofiia); 2004; 43(1):16-20. PubMed ID: 15168648
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Acquired hemophilia as a cause of primary postpartum hemorrhage.
    Borna S; Hantoushzadeh S
    Arch Iran Med; 2007 Jan; 10(1):107-10. PubMed ID: 17198466
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Recombinant activated factor VII (rFVIIa, NovoSeven).
    Agarwal MB; Patnaik M
    J Assoc Physicians India; 2005 Aug; 53():717-20. PubMed ID: 16398083
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Re: Guidelines for the use of recombinant activated factor VII in massive obstetric haemorrhage.
    Nicklin J; Perrin L; Crandon A; Land R; Nascimento M; Obermair A
    Aust N Z J Obstet Gynaecol; 2008 Aug; 48(4):447. PubMed ID: 18837857
    [No Abstract]   [Full Text] [Related]  

  • 29. Life-threatening hemorrhage in neonates: management with recombinant activated factor VII.
    Veldman A; Fischer D; Voigt B; Beyer PA; Schlösser R; Allendorf A; Kreuz W
    Intensive Care Med; 2002 Nov; 28(11):1635-7. PubMed ID: 12415453
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The role of recombinant activated Factor VII in major obstetric haemorrhage: the Farnborough experience.
    Wissa I; Ebeid E; El-Shawarby S; Chandakas S; Kamal T; Hill N
    J Obstet Gynaecol; 2009 Jan; 29(1):21-4. PubMed ID: 19280490
    [TBL] [Abstract][Full Text] [Related]  

  • 31. An open non-randomized study of recombinant activated factor VII in major postpartum haemorrhage.
    Ahonen J; Jokela R; Korttila K
    Acta Anaesthesiol Scand; 2007 Aug; 51(7):929-36. PubMed ID: 17488316
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Congenital factor VII deficiency: therapy with recombinant activated factor VII -- a critical appraisal.
    Mariani G; Konkle BA; Ingerslev J
    Haemophilia; 2006 Jan; 12(1):19-27. PubMed ID: 16409171
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effectiveness of recombinant activated factor VII (rFVII a) for controlling intractable postpartum bleeding: report of two cases and literature review.
    Jirapinyo M; Manonai J; Herabutya Y; Chuncharunee S
    J Med Assoc Thai; 2007 May; 90(5):977-81. PubMed ID: 17596055
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Post-partum hemorrhage: new therapeutic options].
    Franchini M
    Recenti Prog Med; 2007 Jan; 98(1):7-11. PubMed ID: 17345873
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A critical review on the use of recombinant factor VIIa in life-threatening obstetric postpartum hemorrhage.
    Franchini M; Franchi M; Bergamini V; Salvagno GL; Montagnana M; Lippi G
    Semin Thromb Hemost; 2008 Feb; 34(1):104-12. PubMed ID: 18393147
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Use of recombinant factor VIIa for massive postpartum haemhorrage: case series and review of literature.
    Shamsi TS; Hossain N; Soomro N; Hasan JA; Noorani M; Kazi S; Quraishy MS; Jameel B; Sultan ST; Haider S
    J Pak Med Assoc; 2005 Nov; 55(11):512-5. PubMed ID: 16304877
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Successful use of recombinant factor VIIa (NovoSeven) during cardiac surgery in a pediatric patient with Glanzmann thrombasthenia.
    Yilmaz BT; Alioglu B; Ozyurek E; Akay HT; Mercan S; Ozbek N
    Pediatr Cardiol; 2005; 26(6):843-5. PubMed ID: 15690232
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Efficacy of recombinant activated factor VII in unselected patients with uncontrolled haemorrhage: a single centre experience.
    Payne EM; Brett SJ; Laffan MA
    Blood Coagul Fibrinolysis; 2006 Jul; 17(5):397-402. PubMed ID: 16788316
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Recombinant factor VIIa in massive obstetric haemorrhage.
    Bhuskute N; Kritzinger S; Dakin M
    Eur J Anaesthesiol; 2008 Mar; 25(3):250-1. PubMed ID: 18226279
    [No Abstract]   [Full Text] [Related]  

  • 40. Recombinant factor VIIa should be used in massive obstetric haemorrhage.
    Plaat F
    Int J Obstet Anesth; 2007 Oct; 16(4):354-7. PubMed ID: 17698342
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.